Vibration or cool-spray to reduce pain from steroid injections in the hand and wrist
Official title: The Effect of Vibratory Anesthesia on Patient Pain Perception in Corticosteroid Injections of the Upper Extremity
Run by The University of Texas Medical Branch, Galveston · NCT07553273 · Data updated 2026-11-12
This trial tests whether vibration or vapocoolant spray makes corticosteroid injections in the hands, wrists, or elbows less painful for adults with arthritis, tendinopathy, or nerve compression.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 165 (estimated) |
| Sponsor | The University of Texas Medical Branch, Galveston Academic / other |
| Locations | 1 site (Galveston, Texas) |
| Status | Recruiting |
| Started | January 14, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07553273 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow who are scheduled to receive corticosteroid injections are ideal candidates.
✕Probably not a fit
People without bilateral upper-extremity conditions, those unwilling or unable to complete pain ratings, individuals allergic to the injection medications, or those under 18 are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who are already scheduled for bilateral corticosteroid injections in the upper extremities receive two injections—one in each arm—during a single visit and report pain after each injection. The type of local anesthesia for each injection is randomly assigned so each participant receives two of three options: no anesthesia, vibration with the DigiVibe device, or a vapocoolant spray, with some combinations pairing vibration and spray. The DigiVibe device is applied to the skin at the injection site while the injection is given, and participants rate pain using a numeric pain rating scale after each injection. Pain scores for the different anesthesia methods are compared to determine which approach is associated with the least injection pain.
Why it matters
Potential benefit: If successful, the approach could reduce needle pain and increase comfort during routine corticosteroid injections for upper-extremity conditions.
How similar studies have gone: Prior small studies of vibration devices and vapocoolant sprays have shown mixed but generally favorable effects on reducing injection pain.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient of the Principal Investigator who has clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow where treatment with corticosteroid injection is indicated. * Participants who voluntarily consent to participate in the study and sign consent forms. * Participants who complete all numeric pain rating scales * Patients aged ≥ 18 years old Exclusion Criteria: * Participants who opt out of the study or withdraw consent * Participants who are determined to be without capacity to consent to study participation or injection procedure by principal investigator * Participants with inability to complete numeric pain rating scales * Participants with known allergies to triamcinolone acetonide, lidocaine, or bupivicaine * Participants without clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow. * Participants where treatment with corticosteroid injection is not indicated bilaterally. * Patients ≤ 18 years old
Where it's running
-
University of Texas Medical Branch
Galveston, Texas, United States Recruiting
Study contacts
- Study coordinator: John Faillace, MD,FAAOS
- Email: jofailla@utmb.edu
- Phone: 409-772-1011
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating ketorolac for treating upper extremity joint and tendon pain
This study is testing whether ketorolac or triamcinolone injections can help people with joint and tendon pain in their shoulders, elbows, wrists, and hands feel better and improve their function.
-
Hyaluronic Acid vs Platelet-R-rich Plasma for Chronic Tendinopathy and Enthesopathy
This study tests whether injections of hyaluronic acid or autologous platelet-rich plasma can help people with chronic tendon and enthesis problems in the elbow or Achilles area.
-
Restor3D Outcomes Registry: Patient-specific Joint Implants
This registry tests how patients with FDA-cleared restor3d patient-specific implants fare over up to 5 years, by collecting their own reports on pain, function and quality of life after joint replacement surgeries.
-
Camptodactyly–Arthropathy–Coxa Vara–Pericarditis (CACP) syndrome patient registry and genetic review
This registry collects clinical and genetic information to better understand CACP syndrome in children with confirmed PRG4 mutations.
-
Percutaneous electrolysis versus laser for supraspinatus tendon pain
This study will test whether percutaneous electrolysis or laser therapy better reduces pain and improves shoulder function in adults with supraspinatus tendinopathy.
-
Platelet-rich plasma injections for joint and tendon problems
This project will test whether platelet-rich plasma (PRP) injections help people with osteoarthritis and other musculoskeletal conditions reduce pain and improve function over one year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.